Granulocyte	O
-	O
macrophage	O
colony	O
-	O
stimulating	O
factor	O
and	O
interleukin	O
-	O
3	O
enhance	O
the	O
incorporation	O
of	O
cytosine	O
arabinoside	O
into	O
the	O
DNA	O
of	O
leukemic	B-Cell
blasts	I-Cell
and	O
the	O
cytotoxic	O
effect	O
on	O
clonogenic	B-Cell
cells	I-Cell
from	O
patients	O
with	O
acute	B-Cancer
myeloid	I-Cancer
leukemia	I-Cancer
.	O

In	O
the	O
present	O
study	O
the	O
effects	O
of	O
the	O
48	O
-	O
hour	O
administration	O
of	O
granulocyte	O
-	O
macrophage	O
colony	O
-	O
stimulating	O
factor	O
(	O
GM	O
-	O
CSF	O
)	O
(	O
100	O
U	O
/	O
mL	O
)	O
or	O
interleukin	O
-	O
3	O
(	O
IL	O
-	O
3	O
)	O
(	O
100	O
U	O
/	O
mL	O
)	O
on	O
the	O
proliferative	O
activity	O
of	O
leukemic	B-Cell
cells	I-Cell
and	O
on	O
the	O
intracellular	B-Immaterial_anatomical_entity
metabolism	O
and	O
cytotoxic	O
efficacy	O
of	O
a	O
subsequent	O
12	O
-	O
hour	O
application	O
of	O
cytosine	O
arabinoside	O
(	O
ara	O
-	O
C	O
)	O
at	O
doses	O
of	O
0	O
.	O
1	O
,	O
1	O
.	O
0	O
,	O
10	O
.	O
0	O
,	O
and	O
100	O
.	O
0	O
mumol	O
/	O
L	O
were	O
evaluated	O
on	O
bone	B-Cell
marrow	I-Cell
cells	I-Cell
from	O
17	O
patients	O
with	O
acute	B-Cancer
myeloid	I-Cancer
leukemia	I-Cancer
.	O

After	O
GM	O
-	O
CSF	O
or	O
IL	O
-	O
3	O
,	O
a	O
1	O
.	O
2	O
-	O
to	O
2	O
.	O
4	O
-	O
fold	O
increase	O
in	O
S	O
-	O
phase	O
cells	B-Cell
was	O
observed	O
in	O
nine	O
of	O
14	O
GM	O
-	O
CSF	O
and	O
seven	O
of	O
11	O
IL	O
-	O
3	O
cases	O
.	O

3H	O
-	O
Cytosine	O
arabinoside	O
incorporation	O
into	O
the	O
DNA	O
was	O
enhanced	O
1	O
.	O
33	O
-	O
to	O
18	O
.	O
3	O
-	O
fold	O
over	O
respective	O
controls	O
in	O
14	O
of	O
17	O
patients	O
.	O

While	O
in	O
control	O
specimens	B-Cell
are	O
ara	O
-	O
C	O
dose	O
-	O
dependent	O
increase	O
in	O
3H	O
-	O
ara	O
-	O
C	O
uptake	O
was	O
accompanied	O
by	O
a	O
corresponding	O
rise	O
in	O
intracellular	B-Immaterial_anatomical_entity
ara	O
-	O
C	O
-	O
5	O
'	O
triphosphate	O
(	O
ara	O
-	O
CTP	O
)	O
levels	O
,	O
ara	O
-	O
CTP	O
concentrations	O
were	O
not	O
increased	O
after	O
GM	O
-	O
CSF	O
or	O
IL	O
-	O
3	O
exposure	O
,	O
resulting	O
in	O
a	O
higher	O
ara	O
-	O
C	O
to	O
ara	O
-	O
CTP	O
ratio	O
over	O
controls	O
.	O

This	O
finding	O
may	O
be	O
explained	O
by	O
a	O
stimulatory	O
effect	O
of	O
GM	O
-	O
CSF	O
and	O
IL	O
-	O
3	O
on	O
ara	O
-	O
C	O
phosphorylating	O
enzymes	O
and	O
a	O
more	O
rapid	O
incorporation	O
of	O
ara	O
-	O
CTP	O
into	O
the	O
DNA	O
of	O
leukemic	B-Cell
blasts	I-Cell
.	O

These	O
effects	O
translated	O
into	O
a	O
2	O
.	O
2	O
-	O
to	O
229	O
.	O
0	O
-	O
fold	O
increase	O
in	O
the	O
cytotoxic	O
activity	O
of	O
ara	O
-	O
C	O
against	O
clonogenic	B-Cell
leukemic	I-Cell
cells	I-Cell
after	O
GM	O
-	O
CSF	O
or	O
IL	O
-	O
3	O
pretreatment	O
.	O

Hence	O
,	O
GM	O
-	O
CSF	O
and	O
IL	O
-	O
3	O
enhance	O
the	O
intracellular	B-Immaterial_anatomical_entity
metabolism	O
of	O
ara	O
-	O
C	O
and	O
its	O
incorporation	O
into	O
the	O
DNA	O
of	O
leukemic	B-Cell
cells	I-Cell
leading	O
to	O
a	O
higher	O
antileukemic	O
activity	O
of	O
ara	O
-	O
C	O
on	O
clonogenic	B-Cell
leukemic	I-Cell
cells	I-Cell
(	O
CFU	B-Cell
-	I-Cell
L	I-Cell
)	O
.	O

